Back
Anika Therapeutics Quote, Financials, Valuation and Earnings
Election Shock on August 19th?
Click here now to see the evidence I've gathered.
Sell
49
ANIK
Anika Therapeutics
Last Price:
26.47
Seasonality Move:
7.77%
7 Day Trial
ALL ACCESS PASS
$
7
7 Powerhouse Stocks to Buy and Hold Forever
Get it now.Anika Therapeutics Price Quote
$26.47
+0.03 (+1.93%)
(Updated: May 2, 2024 at 5:25 AM ET)
Anika Therapeutics Key Stats
Sell
49
Anika Therapeutics (ANIK)
is a Sell
Day range:
$25.96 - $26.57
52-week range:
$16.54 - $28.13
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.33
P/B ratio:
1.85%
Volume:
63.7K
Avg. volume:
63.5K
1-year change:
1.69%
Market cap:
$392.1M
Revenue:
$166.7M
EPS:
$-5.65
How Much Does Anika Therapeutics Make?
-
How Much Are Anika Therapeutics's Sales Annually?
ANIK Revenues are $166.7M -
How Much Profit Does Anika Therapeutics's Make A Year?
ANIK net income is -$82.7M
Is Anika Therapeutics Growing As A Company?
-
What Is Anika Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.08% -
What Is Anika Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Anika Therapeutics Stock Price Performance
-
Did Anika Therapeutics Stock Go Up Last Month?
Anika Therapeutics share price went up by 2.88% last month -
Did ANIK's Share Price Rise Over The Last Year?
ANIK share price rose by 1.69% over the past 1 year
What Is Anika Therapeutics 52-Week High & Low?
-
What Is Anika Therapeutics’s 52-Week High Share Price?
Anika Therapeutics has traded as high as $28.13 over the past 52 weeks -
What Is Anika Therapeutics’s 52-Week Low Share Price?
Anika Therapeutics has traded as low as $16.54 over the past 52 weeks
Anika Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Anika Therapeutics?
-
How Much Debt Does Anika Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Anika Therapeutics Have?
Cash and short term investments quarterly total is $72.9M -
What Is Anika Therapeutics’s Book Value Per Share?
Book value per share is 14.48
Is Anika Therapeutics Cash Flow Positive?
-
What Is ANIK Cash Flow From Operations?
Cash flow from operations (TTM) is -$1.8M -
What Is Anika Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$6.3M -
What Is Anika Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$5.4M
Anika Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
ANIK return on invested capital is -31.32% -
What Is Anika Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -25.58% -
What Is ANIK Return On Equity?
ROE is a measure of profitability and is -31.32%
Anika Therapeutics Earnings Date & Stock Price
-
What Is Anika Therapeutics's Stock Price Today?
A single share of ANIK can be purchased today for 26.44 -
What Is Anika Therapeutics’s Stock Symbol?
Anika Therapeutics trades on the nasdaq under the ticker symbol: ANIK -
When Is Anika Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Anika Therapeutics is scheduled on May 8, 2024 -
When Is ANIK's next ex-dividend date?
Anika Therapeutics's next ex-dividend date is June 18, 2020 -
How To Buy Anika Therapeutics Stock?
You can buy Anika Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Anika Therapeutics Competitors
-
Who Are Anika Therapeutics's Competitors?
Below is a list of companies who compete with Anika Therapeutics or are related in some way:
Anika Therapeutics Dividend Yield
Data Unavailable
Anika Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 122.06% |
| Revenue: | 8.45% | 3.78% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 30.33 |
| Upside from Last Price: | 14.73% |